Announcements
Sidley Is Representing HeadFirst Global on Its Recommended Offer to Acquire AIM-Listed Impellam Group For Approximately £483.2 Million
December 14, 2023
Sidley is representing HeadFirst Global, the HR services platform, on a recommended offer by a newly formed affiliate to acquire Impellam Group plc, an AIM-listed leading STEM workforce and recruitment group in the UK. The offer is subject to the UK Takeover Code.
Subject to regulatory approval, the deal values the entire issued share capital of Impellam at approximately £483.2 million and is expected to create an enlarged recruitment group for data, tech, and engineering talent, with a strong presence across continental Europe, the UK, and the U.S.
The team was led by James Wood and Ed Perry from Sidley’s M&A and Private Equity team and James Crooks and Chloe Smith from Sidley’s Global Finance group.
Subject to regulatory approval, the deal values the entire issued share capital of Impellam at approximately £483.2 million and is expected to create an enlarged recruitment group for data, tech, and engineering talent, with a strong presence across continental Europe, the UK, and the U.S.
The team was led by James Wood and Ed Perry from Sidley’s M&A and Private Equity team and James Crooks and Chloe Smith from Sidley’s Global Finance group.
Contacts
*Admitted to practice in Scotland. Registered foreign lawyer in England and Wales.
*Only admitted to practice in Scotland. Not admitted to practice in England and Wales.
Offices
Capabilities
Suggested News & Insights
2025 U.S. Private Equity M&A Activity Retrospective & 2026 Market OutlookFebruary 2026Sidley Represents The Brink’s Company in US$6.6 Billion Acquisition of NCR AtleosFebruary 26, 2026Sidley Represents Ancient Financial on Launch and on Its Acquisition of F&G Life Re LtdFebruary 24, 2026Sidley Represents Wafra in Strategic Partnership Between Capital Constellation and Gallatin Point CapitalFebruary 24, 2026Sidley Represents Thermon in Its US$2.2 Billion Combination With CECO EnvironmentalFebruary 24, 2026Sidley Represents Sensei Biotherapeutics in Acquisition of Faeth TherapeuticsFebruary 18, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory



